Matches in SemOpenAlex for { <https://semopenalex.org/work/W2398007370> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2398007370 endingPage "6" @default.
- W2398007370 startingPage "223" @default.
- W2398007370 abstract "Case 1: A 34-year-old woman,who had a right breast cancer with axillary lymph node metastasis and multiple bone metastases, was referred to our clinic. She developed paralysis of lower extremities and disorder of the bladder and rectum due to metastasis to the thoracic vertebra, and also had renal dysfunction due to severe hypercalcemia and hemorrhagic cystitis. Correcting the serum calcium level with intravenous infusion, elcatonin, pamidronate and betamethasone, she underwent radiation therapy for the vertebral metastasis. The first hormonal therapy (leuprorelin/exemestane) had been effective for about 4 months, however the second hormonal therapy (leuprorelin/tamoxifen) was not effective. Chemotherapy with paclitaxel (80 mg/m(2), day 1, 8, 15, every 4 weeks) brought about a stable general condition and a normal level of serum calcium with zoledronate in the ninth month of treatment. Case 2: A 32-year-old woman, who had a right breast cancer with multiple bone metastases and axillary and hilar lymph node metastases, came to our clinic, complaining of nausea due to severe hypercalcemia. After successful correction of hypercalcemia by the intravenous infusion and administration of elcatonin, pamidronate and dexamethasone, the hormonal therapy(goserelin/tamoxifen) caused rapid re-elevation of serum calcium and tumor marker, so that a tumor flare was suspected. After 3 cycles of EC therapy (EPI 90 mg/m(2), CPM 600 mg/m(2), every 3 weeks), 2 cycles of paclitaxel therapy (80 mg/m(2), day 1, 8, 15, every 4 weeks) brought about tumor reduction and the normal level of serum calcium. After 7 cycles of paclitaxel therapy,the hormonal therapy (goserelin/tamoxifen) proved effective for several months. To achieve tumor reduction and stabilize the serum calcium level, we need to start immediately the treatment of breast cancer with severe hypercalcemia, considering the general condition of the patient." @default.
- W2398007370 created "2016-06-24" @default.
- W2398007370 creator A5001451790 @default.
- W2398007370 creator A5014133673 @default.
- W2398007370 creator A5035071748 @default.
- W2398007370 creator A5038410222 @default.
- W2398007370 creator A5049566103 @default.
- W2398007370 creator A5050821649 @default.
- W2398007370 creator A5076295024 @default.
- W2398007370 creator A5087660235 @default.
- W2398007370 creator A5088357278 @default.
- W2398007370 date "2006-02-01" @default.
- W2398007370 modified "2023-09-26" @default.
- W2398007370 title "[Two cases of stage IV breast cancer with severe hypercalcemia]." @default.
- W2398007370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16484860" @default.
- W2398007370 hasPublicationYear "2006" @default.
- W2398007370 type Work @default.
- W2398007370 sameAs 2398007370 @default.
- W2398007370 citedByCount "1" @default.
- W2398007370 crossrefType "journal-article" @default.
- W2398007370 hasAuthorship W2398007370A5001451790 @default.
- W2398007370 hasAuthorship W2398007370A5014133673 @default.
- W2398007370 hasAuthorship W2398007370A5035071748 @default.
- W2398007370 hasAuthorship W2398007370A5038410222 @default.
- W2398007370 hasAuthorship W2398007370A5049566103 @default.
- W2398007370 hasAuthorship W2398007370A5050821649 @default.
- W2398007370 hasAuthorship W2398007370A5076295024 @default.
- W2398007370 hasAuthorship W2398007370A5087660235 @default.
- W2398007370 hasAuthorship W2398007370A5088357278 @default.
- W2398007370 hasConcept C121608353 @default.
- W2398007370 hasConcept C126322002 @default.
- W2398007370 hasConcept C126894567 @default.
- W2398007370 hasConcept C141071460 @default.
- W2398007370 hasConcept C2777176818 @default.
- W2398007370 hasConcept C2778311097 @default.
- W2398007370 hasConcept C509974204 @default.
- W2398007370 hasConcept C530470458 @default.
- W2398007370 hasConcept C71924100 @default.
- W2398007370 hasConceptScore W2398007370C121608353 @default.
- W2398007370 hasConceptScore W2398007370C126322002 @default.
- W2398007370 hasConceptScore W2398007370C126894567 @default.
- W2398007370 hasConceptScore W2398007370C141071460 @default.
- W2398007370 hasConceptScore W2398007370C2777176818 @default.
- W2398007370 hasConceptScore W2398007370C2778311097 @default.
- W2398007370 hasConceptScore W2398007370C509974204 @default.
- W2398007370 hasConceptScore W2398007370C530470458 @default.
- W2398007370 hasConceptScore W2398007370C71924100 @default.
- W2398007370 hasIssue "2" @default.
- W2398007370 hasLocation W23980073701 @default.
- W2398007370 hasOpenAccess W2398007370 @default.
- W2398007370 hasPrimaryLocation W23980073701 @default.
- W2398007370 hasRelatedWork W1526579036 @default.
- W2398007370 hasRelatedWork W1979381030 @default.
- W2398007370 hasRelatedWork W2026596113 @default.
- W2398007370 hasRelatedWork W2116918238 @default.
- W2398007370 hasRelatedWork W2136378729 @default.
- W2398007370 hasRelatedWork W2141798191 @default.
- W2398007370 hasRelatedWork W2393893753 @default.
- W2398007370 hasRelatedWork W2428341374 @default.
- W2398007370 hasRelatedWork W2499620631 @default.
- W2398007370 hasRelatedWork W2966339785 @default.
- W2398007370 hasVolume "33" @default.
- W2398007370 isParatext "false" @default.
- W2398007370 isRetracted "false" @default.
- W2398007370 magId "2398007370" @default.
- W2398007370 workType "article" @default.